These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31719809)

  • 21. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units.
    Stover BH; Shulman ST; Bratcher DF; Brady MT; Levine GL; Jarvis WR;
    Am J Infect Control; 2001 Jun; 29(3):152-7. PubMed ID: 11391276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug incompatibilities in the adult intensive care unit of a university hospital.
    Marsilio NR; Silva Dd; Bueno D
    Rev Bras Ter Intensiva; 2016 Jun; 28(2):147-53. PubMed ID: 27410410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards more efficient use of intravenous lumens in multi-infusion settings: development and evaluation of a multiplex infusion scheduling algorithm.
    Doesburg F; Oelen R; Renes MH; Bult W; Touw DJ; Nijsten MW
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):206. PubMed ID: 32878609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compatibility of medications during multi-infusion therapy: A controlled in vitro study on a multilumen infusion device.
    Perez M; Décaudin B; Foinard A; Barthélémy C; Debaene B; Lebuffe G; Odou P
    Anaesth Crit Care Pain Med; 2015 Apr; 34(2):83-8. PubMed ID: 25858619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. End-of-life opioid administration on neonatal and pediatric intensive care units: nurses' attitudes and practice.
    Garten L; Daehmlow S; Reindl T; Wendt A; Münch A; Bührer C
    Eur J Pain; 2011 Oct; 15(9):958-65. PubMed ID: 21531155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication Safety in Intravenous Therapy: A Compatibility Study of Clonidine with Drugs Frequently Used in Intensive Care.
    Koller AK; Krebs S; Dörje F
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review.
    Castells Lao G; Rodríguez Reyes M; Roura Turet J; Prat Dot M; Soy Muner D; López Cabezas C
    Med Intensiva (Engl Ed); 2020 Mar; 44(2):80-87. PubMed ID: 30262380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of seven i.v. drug compatibility references by using requests from a drug information center.
    Smith WD; Karpinski JP; Timpe EM; Hatton RC
    Am J Health Syst Pharm; 2009 Aug; 66(15):1369-75. PubMed ID: 19635773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
    Ng E; Taddio A; Ohlsson A
    Cochrane Database Syst Rev; 2003; (1):CD002052. PubMed ID: 12535424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential drug incompatibilities in the neonatal intensive care unit: a network analysis approach.
    Leopoldino RW; Costa HT; Costa TX; Martins RR; Oliveira AG
    BMC Pharmacol Toxicol; 2018 Dec; 19(1):83. PubMed ID: 30522525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug infusions in a Swiss palliative care unit: assessment of frequent combinations in terms of clinical effectiveness, compatibility, and stability.
    Fusi-Schmidhauser T; Caronzolo D; Gamondi C
    Support Care Cancer; 2016 Dec; 24(12):4971-4978. PubMed ID: 27448404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion.
    Pleasants RA; Vaughan LM; Williams DM; Fox JL
    Ann Pharmacother; 1992 Oct; 26(10):1221-6. PubMed ID: 1421642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
    Greenhill K; Hornsby E; Gorman G
    Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31060247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
    Ng E; Taddio A; Ohlsson A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002052. PubMed ID: 28141899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No resuscitation and withdrawal of therapy in a neonatal and a pediatric intensive care unit in Canada.
    Ryan CA; Byrne P; Kuhn S; Tyebkhan J
    J Pediatr; 1993 Oct; 123(4):534-8. PubMed ID: 8410503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice Change From Intermittent Medication Boluses to Bolusing From a Continuous Infusion in Pediatric Critical Care: A Quality Improvement Project.
    Hochstetler JL; Thompson AJ; Ball NM; Evans MC; Frame SC; Haney AL; Little AK; O'Donnell JL; Rickett BM; Mack EH
    Pediatr Crit Care Med; 2018 Jun; 19(6):572-577. PubMed ID: 29652752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deaths and end-of-life decisions differed between neonatal and paediatric intensive care units at the same children's hospital.
    Snoep MC; Jansen NJG; Groenendaal F
    Acta Paediatr; 2018 Feb; 107(2):270-275. PubMed ID: 28871637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
    Meyer K; Santarossa M; Danziger LH; Wenzler E
    Hosp Pharm; 2017 Mar; 52(3):221-228. PubMed ID: 28439137
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical stability of ondansetron hydrochloride with other drugs in admixtures via parenteral; a review.
    Estan-Cerezo G; Jiménez-Pulido I; Rodríguez Lucena FJ; Matoses Chirivella C; Soriano-Irigaray L; Navarro-Ruiz A
    Farm Hosp; 2017 Sep; 41(5):625-629. PubMed ID: 28847252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physical Compatibility of Y-site Pediatric Drug Administration: A Call for Question of US Pharmacopeia Standards.
    Ross EL; Petty K; Salinas A; Bremmer J; Her C; Carpenter JF
    J Pediatr Pharmacol Ther; 2023; 28(1):84-92. PubMed ID: 36777987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.